Connection
Barry Uretsky to Adenosine A2 Receptor Agonists
This is a "connection" page, showing publications Barry Uretsky has written about Adenosine A2 Receptor Agonists.
|
|
Connection Strength |
|
 |
|
 |
|
0.463 |
|
|
|
-
Hakeem A, Uretsky B. Regadenoson for FFR: time to say good-bye to adenosine? Catheter Cardiovasc Interv. 2014 Feb 15; 83(3):375-6.
Score: 0.463